BG Medicine Inc BGMD Stock Analysis
- PINK
- Stock
- Market closed · opens Monday 9:30 AM ET
$0.00 unchanged at close Nov 6
Last close · Previous close $0.00
- 52-week change
- up $0.00, 9,900.00%Price only
- Distributions
- $0.00Per share, last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$0.00unchangedPast month
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.00Nov 5
- Volume0.00Nov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume36.00Last 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $0.00 to $0.00; now $0.00
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
BGMD beat the S&P 500 in 4 of 7 periods.
| Period | BGMD and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | BGMD: unchanged S&P 500: down 5.6% | BGMD beat the S&P 500 by 5.6 percentage points Beat |
| 3M | BGMD: unchanged S&P 500: down 4.1% | BGMD beat the S&P 500 by 4.1 percentage points Beat |
| YTD | BGMD: up 9,900.0% S&P 500: up 8.7% | BGMD beat the S&P 500 by 9,891.3 percentage points Beat |
| 1Y | BGMD: up 9,900.0% S&P 500: up 10.9% | BGMD beat the S&P 500 by 9,889.1 percentage points Beat |
| Long term | ||
| 3Y | BGMD: unchanged S&P 500: up 75.0% 0.0% vs +20.5% a year | BGMD trailed the S&P 500 by 75.0 percentage points Trailed |
| 5Y | BGMD: unchanged S&P 500: up 67.8% 0.0% vs +10.9% a year | BGMD trailed the S&P 500 by 67.8 percentage points Trailed |
| 10Y | BGMD: down 99.9% S&P 500: up 313.1% −52.7% vs +15.2% a year | BGMD trailed the S&P 500 by 413.0 percentage points Trailed |
$10,000 invested in BGMD 10 years ago (Nov 4, 2016) would be worth about $6 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,313.
BGMD beat the S&P 500 in 4 of 7 periods.
| Period | BGMD and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | BGMD: unchanged S&P 500: down 5.6% | BGMD beat the S&P 500 by 5.6 percentage points Beat |
| 3M | BGMD: unchanged S&P 500: down 4.3% | BGMD beat the S&P 500 by 4.3 percentage points Beat |
| YTD | BGMD: up 9,900.0% S&P 500: up 7.8% | BGMD beat the S&P 500 by 9,892.2 percentage points Beat |
| 1Y | BGMD: up 9,900.0% S&P 500: up 9.7% | BGMD beat the S&P 500 by 9,890.3 percentage points Beat |
| Long term | ||
| 3Y | BGMD: unchanged S&P 500: up 68.8% 0.0% vs +19.1% a year | BGMD trailed the S&P 500 by 68.8 percentage points Trailed |
| 5Y | BGMD: unchanged S&P 500: up 56.9% 0.0% vs +9.4% a year | BGMD trailed the S&P 500 by 56.9 percentage points Trailed |
| 10Y | BGMD: down 99.9% S&P 500: up 252.6% −52.7% vs +13.4% a year | BGMD trailed the S&P 500 by 352.5 percentage points Trailed |
$10,000 invested in BGMD 10 years ago (Nov 4, 2016) would be worth about $6 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,257.
All-time high
$41.60
Closing high on . Now 100.0% below that record.
Split-adjusted daily closes since Feb 4, 2011.
Stock splits
1
1-for-4 on . Share counts adjust after each split.
About BG Medicine Inc
BG Medicine, Inc. (BG Medicine) is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics to addresses unmet medical needs. The Company focuses on blood-based tests. Its lead product candidate in development is CardioSCORE, which is a multi-analyte biomarker-based blood test for atherothrombotic cardiovascular disease, commonly known as vulnerable plaque. In March 2011, the Company entered into a supply agreement with Health Diagnostic Laboratory, Inc. (HDL), pursuant to which HDL agreed to purchase manual galectin-3 test kits from the Company and to offer galectin-3 testing services to physicians in the United States. This manual version of Its Galectin-3 test is being marketed in the United States through a number of regional and national laboratory testing facilities. In addition, it has partnered with four diagnostic instrument manufacturers, which are developing automated instrument versions of its galectin-3 test.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Massachusetts, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- PINK
- Asset type
- Common stock
- Price history since
BGMD news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
BGMD stock FAQ
What is BGMD stock’s price today?
BG Medicine (BGMD) traded at $0.00 at the close on , unchanged from the previous close of $0.00. Over the past 52 weeks it has traded between $0.00 and $0.00.
If you invested $1,000 in BGMD 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in BGMD on would be worth about $1 at the close on , a total return of −99.9%. The same $1,000 would be worth $1,000 if invested five years ago and $100,000 if invested one year ago. Past performance doesn’t predict future returns.
What is BG Medicine’s market cap?
BG Medicine’s market capitalization is about $1.1 thousand. That’s Tiingo’s daily market cap for , at that day’s closing price of $0.00 (how market cap works).
Does BGMD pay a dividend?
BG Medicine hasn’t paid a dividend in the last twelve months.
What is BGMD’s 52-week high and low?
Over the past 52 weeks BGMD has traded as low as $0.00 and as high as $0.00. At $0.00 at the close on , it is 0.0% below that high and 9,900.0% above the low.
What is BGMD’s all-time high?
BGMD’s highest closing price was $41.60 on , adjusted for stock splits. At $0.00 at the close on , it is 100.0% below that record.
Has BGMD stock ever split?
Yes, once: 1-for-4 on .
How has BGMD stock performed?
Including dividends and measured to the close on , BGMD has returned +9,900.0% so far this year and +9,900.0% over the past year, and 0.0% over five years (0.0% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What sector and industry is BG Medicine in?
BG Medicine is in the Healthcare sector and the Diagnostics & Research industry, and is headquartered in Massachusetts, USA.
What exchange does BGMD trade on?
BG Medicine trades on the PINK under the ticker symbol BGMD. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.